When Sam was diagnosed with medulloblastoma in 2009, it was thought to be a single type of cancer, and there were only two treatment paths — one for infants and one for older children. St. Jude researchers have led the way in better understanding medulloblastoma in order to maximize the effectiveness of treatment while minimizing the side effects. But conducting research is not the final step. Research data must be accessible. In keeping with there mission, St. Jude created a portal, available to doctors around the world, with point-and-click tools to help doctors use the data to select the most effective treatment plans.
Click here to read the article on this breakthrough research.
Your support of St. Jude and SamStrong makes this research possible.